INTRODUCTION
The primary mechanism of activation of smooth-muscle contraction involves phosphorylation of the 20 kDa light chains of myosin (LC #! ) catalysed by myosin light-chain kinase (MLCK) [1] . Contractile stimuli lead to LC #! phosphorylation primarily at Ser-19 in both intact and permeabilized smooth muscle (e.g. [2] [3] [4] ). LC #! monophosphorylated at Ser-19 can be phosphorylated further by MLCK at Thr-18 to produce diphosphorylated LC #! ; this has been demonstrated in itro using high levels of MLCK [5, 6] and, in some instances, in intact [2] and permeabilized smooth muscle [3] . Diphosphorylated myosin exhibits a greater actin-activated MgATPase activity than myosin phosphorylated only at Ser-19 [5] , but the velocity of movement of both forms of myosin in the in itro motility assay is the same [7] . Protein kinase C (PKC) can phosphorylate LC #! at Ser-1, Ser-2 and Thr-9 in itro [8] , but this does not increase the actinactivated myosin MgATPase activity [8] or evoke movement in the in itro motility assay [7] . Furthermore, phosphorylation of myosin at PKC-specific sites has not been observed in intact smooth muscle in response to agonists that activate PKC (e.g. [2, 4, 9, 10] ). PKC may, however, indirectly cause increases in LC #! phosphorylation at Ser-19 and Thr-18 via inhibition of myosin light-chain phosphatase (myosin-associated type-1 phosphatase ;
with the quantitative loss of PKCs α and β following detergent treatment ; (iv) very little LC #! diphosphorylation (i.e. Thr-18 phosphorylation) occurs in intact or demembranated RTA at rest or in response to contractile stimuli ; and (v) the level of LC #! phosphorylation correlates with contraction in intact and demembranated RTA, although the steady-state tension-LC #! phosphorylation relationship is markedly different between the two preparations such that the basal level of LC #! phosphorylation in intact muscles is sufficient to generate maximal force in demembranated preparations. This may be due, in part, to differences in the phosphatase\kinase activity ratio, resulting from disruption of a signalling pathway leading to myosin lightchain phosphatase inhibition following detergent treatment.
Key words : contraction, myosin light-chain phosphorylation, protein kinase, vascular smooth muscle. PP1 M ), leading to contraction [11] [12] [13] . Recently, regulation of PP1 M has been shown to involve a PKC substrate, CPI-17, that in the phosphorylated state is a potent inhibitor of the phosphatase [14] [15] [16] . Phosphorylation of CPI-17 occurs in intact arterial smooth muscle in response to agonist stimulation [17] . This protein is expressed in smooth-muscle tissues, but little expression was detected in heart, skeletal muscle or non-muscle tissues [18] . An atypical PKC isoform activated by arachidonic acid may also inhibit PP1 M activity [19] . Furthermore, the 130 kDa myosin-binding subunit of PP1 M (MYPT) can be phosphorylated, and the phosphatase activity inhibited, by Rhoassociated kinase (ROK) [20] or an unidentified, chelerythrinesensitive but calphostin C-insensitive kinase [21] . ROK is also capable of directly phosphorylating LC #! , primarily at Ser-19 [22, 23] , although this does not appear to occur in situ [24] [25] [26] . Recently, ROK has been shown to phosphorylate CPI-17 at Thr-38 (the PKC site) with a marked increase in PP1 M inhibition [27] . Finally, a Ca# + -independent kinase distinct from MLCK but catalysing phosphorylation of LC #! at Ser-19 and\or Thr-18 was recently detected in rat tail arterial and chicken gizzard smooth muscles [28] .
The goals of the present study were : (i) to determine the relative importance of MLCK and PKC in phosphorylation of LC #! during unstimulated, and agonist-and Ca# + -stimulated conditions in intact or demembranated rat tail arterial smoothmuscle strips ; (ii) to determine the relationship between LC #! phosphorylation and steady-state force development in intact and demembranated rat tail arterial smooth muscle ; and (iii) to determine the involvement of LC #! diphosphorylation in contraction of this vascular smooth muscle. LC #! phosphorylation was quantified by urea\glycerol PAGE and immunoblotting using three antibodies : one that recognizes all forms of LC #! (phosphorylated or unphosphorylated) [4] , one that recognizes only LC #! phosphorylated at Ser-19, and one that recognizes only LC #! phosphorylated at both Ser-19 and Thr-18 [29] . Four kinase inhibitors were used to investigate the kinases involved in LC #! phosphorylation : two MLCK inhibitors (ML-9 and wortmannin) and two PKC inhibitors (chelerythrine and calphostin C). In addition, the type-1 and -2A phosphatase inhibitor microcystin was used to inhibit PP1 M in demembranated arterial muscle strips.
MATERIALS AND METHODS

Materials
Hepes, Tes and PMSF were purchased from Sigma-Aldrich (Oakville, Ontario, Canada). Triton X-100 was purchased from Boehringer Mannheim (Indianapolis, IN, U.S.A.). Microcystin-LR from Microcystis aeruginosa, ML-9 [1-(5-chloronaphthalene-1-sulphonyl)-1H-hexahydro-1,4-diazepine], wortmannin, calphostin C and chelerythrine were purchased from Calbiochem (La Jolla, CA, U.S.A.). Microcystin specifically inhibits type-1 and -2A protein serine\threonine phosphatases with an IC &! of 100 nM [30] . ML-9 is a selective inhibitor of MLCK (K i 3.8 µM) that is competitive with respect to ATP [31] . Wortmannin is well known as a potent inhibitor of phosphatidylinositol 3-kinase (IC &! 10 nM) [32] but is also commonly used as a MLCK inhibitor (IC &! 0.17 µM) ; it acts as a non-competitive inhibitor with respect to ATP [33] . Chelerythrine (IC &! 0.66 µM) is a selective, competitive inhibitor of PKC with respect to the protein substrate and a non-competitive inhibitor with respect to ATP [34] . Calphostin C (IC &! 50 nM), on the other hand, inhibits PKC by direct interaction with the regulatory domain, competing at the binding site of diacylglycerol and phorbol esters [35] . Stock solutions were prepared in water for microcystin, in 50 % (v\v) ethanol for ML-9 and in DMSO for wortmannin, calphostin C and chelerythrine. Calmodulin was isolated as described previously [36] . Cirazoline was provided generously by Dr C. R. Triggle (University of Calgary, Calgary, Alberta, Canada). Anti-PKCζ (a polyclonal antibody raised against the C-terminal sequence GFEYINPLLLSAEESV) was purchased from Life Technologies. Anti-caldesmon [37] and anti-calponin [38] were characterized previously. Anti-MLCK, anti-MYPT and anti-PP1 c (raised against the catalytic subunit of type-1 protein phosphatase) were provided generously by Dr David Hartshorne (University of Arizona, Tucson, AZ, U.S.A.). All other reagents were of analytical grade or better and were purchased from VWR-CanLab (Edmonton, Alberta, Canada) or Sigma-Aldrich Canada (Mississauga, Ontario, Canada).
Tissue isolation and contractility measurement
Male Sprague-Dawley rats (300-500 g) were anaesthetized by inhalation of a lethal dose of halothane according to a research protocol consistent with the standards of the Canadian Council on Animal Care and approved by the local Animal Care Committee of the Medical Research Council of Canada. Rat tail arteries were cleaned and the endothelial cell layer removed mechanically. Helical strips ($ 1 mmi5-7 mm) were cut and tied between a solid support and a force transducer, either horizontally on a bubble plate or vertically in a cuvette. Solution changes were effected rapidly by rotation of the bubble plate or replacement of the solution in the cuvette with a pipette. A resting tension of 50 mg was applied to all strips, which were equilibrated for 30-45 min in Hepes-Tyrode buffer (10 mM Hepes\137 mM NaCl\2.7 mM KCl\1 mM MgCl # \ 1.8 mM CaCl # \5.6 mM glucose, pH 7.4). All buffers were at room temperature (20 mC) and those used for intact strips were pre-oxygenated with 100 % O # .
Intact strips
An initial reference contraction to 0.3 µM cirazoline was obtained. After 3i15 min washes in Hepes-Tyrode buffer, relaxed strips were treated with vehicle (water, DMSO or ethanol) or inhibitors of MLCK or PKC for 30 min. For basal studies, strips were frozen immediately after the 30 min incubation with the inhibitor. For studies with cirazoline, strips were then exposed to the same inhibitor in the presence of 0.3 µM cirazoline and rapidly frozen at the plateau of the sustained tonic component of the contraction.
Demembranated strips
While still intact, strips were contracted repeatedly with 117 mM KCl in Hepes-Tyrode buffer (with equimolar NaCl removed) until similar levels of force were obtained. The strips were demembranated in the bath with 1 % (w\v) Triton X-100 in 30 mM Tes\50 mM KCl\5 mM K # EGTA\150 mM sucrose\ 0.5 mM dithioerythritol, pH 7.4, for 2 h at room temperature. Solutions for experiments with demembranated arterial smoothmuscle strips contained 3.2 mM MgATP, 2 mM free Mg# + , 12 mM phosphocreatine, 0.5 mM NaN $ , 15 units\ml creatine kinase, 1 µM calmodulin and 30 mM Tes (pH 6.9), with ionic strength adjusted to 150 mM with potassium propionate. Desired free Ca# + concentrations (expressed as klog[Ca# + ] or pCa) were obtained by mixing stock solutions containing K # EGTA and K # CaEGTA [39] . Tissues were incubated with inhibitors of MLCK or PKC in a pCa 9 solution for 30 min, followed by addition of the same inhibitor in a pCa 6 solution. Strips were frozen at the plateau of force development.
For analysis of the efficiency of demembranation, intact and Triton X-100-demembranated rat tail arterial smooth-muscle strips (17 strips, each $ 6 cm long) were lyophilized, weighed (16.9 and 16.8 mg of dry weight, respectively) and homogenized with a Tissue Tearor model 985-370 (BioSpec Products, Bartlesville, OK, U.S.A.) for 3i10 s in 1 ml of 20 mM Tris\HCl, pH 7.5\2 mM EDTA\2 mM EGTA\1 mM dithiothreitol (DTT)\0.1 mM PMSF\10 µg\ml leupeptin\1 µg\ml pepstatin\ 1 % (w\v) SDS\0.1 mg\ml soya bean trypsin inhibitor. The homogenate was transferred to a centrifuge tube, the homogenizer blade and homogenization tube rinsed with 6i250 µl of homogenization buffer and combined with the initial homogenate prior to centrifugation at 100 000 g for 1 h at 20 mC in a Beckman TL-100 table-top ultracentrifuge. Samples were subjected to SDS\PAGE (7.5-20 % polyacrylamide gradient gels) and stained with Coomassie Brilliant Blue as described previously [38] or subjected to Western blotting (see below).
Measurement of LC 20 phosphorylation
Muscle strips were frozen by immersion in a slurry of solid CO # with 10 % (w\v) trichloroacetic acid\10 mM DTT in acetone for 1 min initially, then for another 10 min after removal from the force transducer and support. Strips were washed in 10 mM Smooth-muscle myosin phosphorylation DTT in acetone, lyophilized overnight and stored at k80 mC until LC #! extraction. Proteins were extracted from tissue strips in 100 µl of 6 M urea\200 mM Tris\220 mM glycine\10 mM DTT\10 mM EGTA\1 mM EDTA\1 mM PMSF\0.6 M KI\ 0.1 % (w\v) Bromphenol Blue by constant rotation in a microcentrifuge tube for 3 h at 20 mC. After filtration through a 0.45 µm Centricon filter (Millipore, Bedford, MA, U.S.A.), unphos-
were separated by urea\ glycerol PAGE using a modification of the method of Sobieszek and Jertschin [40] using 0.75 mm-thick mini slab gels and 30 µl of sample\lane. Electrophoresis was carried out at 6 mA\gel for 5 h. Proteins were transferred to 0.2 µm nitrocellulose membranes in 10 mM sodium cyclohexylaminopropane sulphonic acid (pH 11.0) in a large transblot cell at 20 V and 4 mC for 16 h. Western blotting was performed using three different antibodies : anti-LC #! (a polyclonal antibody raised in rabbits against chicken gizzard LC #! that recognizes all phosphorylated and unphosphorylated forms of LC #! ) was used at 1 : 5000 dilution [4] ; antibody pLC1 (a monoclonal antibody that recognizes LC #! phosphorylated only at Ser-19) was used at 1 : 200 dilution [29] ; and antibody pLC2 (a peptide-directed polyclonal antibody raised in rabbits that specifically recognizes LC #! phosphorylated at both Ser-19 and Thr-18) was used at 1 : 5000 dilution [29] . Membranes were then incubated with horseradish peroxidaseconjugated secondary antibody (anti-rabbit or anti-mouse, both purchased from Boehringer Mannheim and used at 1 : 5000 dilution) and developed with the Supersignal TM CL-HRP Substrate System (Pierce Chemical Co., Rockford, IL, U.S.A.) as described by the manufacturer. LC #! phosphorylation was quantified by densitometric scanning using a Pharmacia Image Master Desktop Scanning System. In separate experiments we established the linear range for the relationship between LC #! signal intensity (Aimm#) and protein amount. The specificity of these antibodies has been characterized previously [4, 29] .
Western blotting
Proteins separated by SDS\PAGE were transferred to nitrocellulose membranes (0.2 µm) in 25 mM Tris\192 mM glycine\ 20 % (v\v) methanol\0.1 % (w\v) SDS, pH 8.3, at 40 V and 4 mC for 16 h. Subsequent procedures were as described previously [28] using polyclonal antibodies raised in rabbits (anti-PKCζ, 5 µg\ml ; anti-calponin, 1 : 5000 dilution ; anti-caldesmon, 1 : 10 000 dilution ; anti-MLCK, 1 : 500 dilution ; and anti-PP1 c , 1 : 2000 dilution) or a monoclonal antibody to MYPT (1 : 2000 dilution). Secondary antibodies and enhanced chemiluminescence detection were as described above.
Involuted rings of rat tail artery were threaded on to glass capillaries (0.35 mm diameter) and loaded with 16 µM fura 2 acetoxymethyl ester (fura 2\AM) for 3-4 h at room temperature. They were then mounted in a perfusion bath on top of an inverted microscope for recording of epifluorescence at 510 nm with excitation at 340 and 380 nm as described previously [41] . The perfusion inlet was directed on to the tissue at a distance of 1 mm and solution from pre-equilibration reservoirs was changed by switching a magnetic valve. Fura 2 measurements were carried out at room temperature.
Data calculation and statistics
LC
#! phosphorylation was quantified by Western blotting using anti-LC #! that recognizes all species of LC #! . Monophosphorylation levels are expressed as the percentage of total LC
Vehicle treatment (ethanol and\or DMSO at 0.5 %, v\v) of either intact or demembranated rat tail arterial smooth-muscle strips did not significantly alter contractile or LC #! phosphorylation responses compared with untreated controls ; these control groups were therefore combined. Values are presented as meanspS.E.M. Data were compared by one-way analysis of variance, followed by modified Bonferroni posteriori tests, as appropriate. A level of P 0.05 was considered to be statistically significant.
RESULTS
Basal LC 20 phosphorylation
The primary purpose of this work was to determine the relative importance of MLCK and PKC in regulating myosin phosphorylation at Ser-19 and Thr-18 under basal conditions and during α " -adrenoceptor stimulation of vascular smooth muscle. The basal level of P " -LC #! in intact rat tail artery was 18.4p2.2 % (0.184p0.022 mol of P i \mol of LC #! , n l 6 ; Figure  1 ). P # -LC #! was also detected in intact rat tail arterial smooth muscle under resting conditions using antibody pLC2, which recognizes LC #! only when phosphorylated at both Ser-19 and Thr-18 ( Figure 2D , lane 2). However, the stoichiometry of diphosphorylation was very low (estimated to be 5 %) since P # -LC #! could not be detected using anti-LC #! ( Figure 2C , lane 2), which recognizes all three forms of LC #! (unphosphorylated, mono-and diphosphorylated ; Figure 2C , lane 1). We used two MLCK inhibitors and two PKC inhibitors with different mechanisms of action to identify the kinase(s) responsible for basal phosphorylation of LC #! . Figure 1 shows that basal LC #! monophosphorylation was significantly reduced by the MLCK inhibitors ML-9 and wortmannin, but not by the PKC inhibitors chelerythrine or calphostin C, indicating that MLCK is responsible for basal monophosphorylation.
Agonist-induced LC 20 phosphorylation in intact muscle
The α " -adrenergic agonist cirazoline (0.3 µM) induced a biphasic contraction of de-endothelialized rat tail arterial smooth-muscle strips, consisting of a rapid increase in force in the first 30 s after stimulation followed by a slower increase in force to a sustained steady-state level (Figure 2A) . A representative Western blot to determine LC #! phosphorylation at 30 s and 5 min, using an antibody that recognizes all forms of LC #! , is shown in Figure  2 (C), lanes 7 and 8, and quantification of LC #! phosphorylation in response to α " -adrenoceptor stimulation is shown in Figure  2 (A). The tonic and phasic components of cirazoline-induced contraction were both accompanied by an increase in LC #! monophosphorylation (Figure 2A) , which occurred at Ser-19 ( Figure 2C, lanes 11 and 12) . A very low level of LC #! diphosphorylation was detected following cirazoline treatment ( Figure 2D, lanes 7 and 8) .
For comparison, Figure 2 (B) shows the contractile response of de-endothelialized rat tail arterial smooth-muscle strips to a maximal depolarizing KCl stimulus. Contraction peaked at $ 30 s and declined slowly with time. K + depolarization evoked a rapid $ 4-fold increase in LC #! monophosphorylation that correlated with the rapid increase in force, and then LC #! monophosphorylation declined to resting levels by 5 min while force declined more slowly : 56 % of maximal K + -induced force was maintained at 5 min. A representative Western blot showing the time course of LC #! phosphorylation evoked by K + depolarization is shown in Figure 2 (C), lanes 3-6. P " -LC #! was recognized by antibody pLC1, specific for LC #! phosphorylated at Ser-19 ( Figure 2C, lanes 9 and 10) . It is evident from the Western blot in Figure 2 (C), lanes 3-6, that very little diphosphorylation of LC #! occurred in response to K + -induced depolarization, since no immunoreactive band corresponding to P # -LC #! was detected with anti-LC #! . We estimate that we should have been able to detect 5 % P # -LC #! with this antibody. However, K + -induced LC #! diphosphorylation was clearly visualized using the very sensitive antibody pLC2, recognizing only LC #! phosphorylated at both Ser-19 and Thr-18 ( Figure 2D, lanes 3-6) . The time course of LC #! diphosphorylation was very similar to that of monophosphorylation (compare Figure 2D , lanes 2-6 with Figure 2B ), but clearly the stoichiometry of diphosphorylation was very low. 
Cirazoline-induced contraction and LC
#! monophosphorylation were sensitive to inhibition by the MLCK inhibitors ML-9 and wortmannin ( Figure 3 ) and the PKC inhibitors chelerythrine and calphostin C (Figure 4 ), indicating that MLCK and PKC are involved in cirazoline-induced LC #! monophosphorylation and contraction.
Using fura 2-loaded intact rat tail arterial muscle strips, we verified that neither chelerythrine nor calphostin C had any significant effect on resting [ 
Characterization of intact and demembranated rat tail arterial smooth muscle
Prior to conducting experiments with Triton X-100-demembranated rat tail arterial strips, we compared the protein contents of this preparation and of intact muscle strips. The efficiency of demembranation and the protein composition of intact and demembranated rat tail arterial smooth-muscle strips are shown in Figure 6 . Figure 6(A) shows that the cytoskeletal, contractile and regulatory proteins are completely retained following demembranation with Triton X-100 and that there is no evidence of proteolysis following Triton X-100 treatment. Closer inspection reveals the loss of several proteins, presumably cytosolic and membrane-bound proteins, following detergent treatment ; some are indicated by arrowheads. The Western blots in Figures  6(B)-6 (G) demonstrate the efficiency of extraction of soluble and detergent-solubilized proteins more clearly : PKC isoenzymes ζ, α and β are completely removed ( Figure 6B ) while the actinbinding proteins calponin, caldesmon and MLCK ( Figures  6C-6E ) and the myosin-binding PP1 M [both the 130 kDa myosinbinding subunit (MYPT or M130) and the 38 kDa catalytic subunit (PP1 c )] are quantitatively retained ( Figures 6F and 6G) . We have shown previously that Triton X-100-demembranated rat tail arterial smooth-muscle strips generate comparable force in response to Ca# + as intact strips in response to K + depolarization [28] . We conclude, therefore, that Triton X-100 treatment effectively removes cytosolic and membrane proteins without affecting the contractile machinery. 
Ca 2 + -induced LC 20 phosphorylation in demembranated muscle
In Triton X-100-demembranated rat tail arterial smooth muscle, in contrast to intact rat tail artery, no basal (i.e. at pCa 9) LC #! phosphorylation was detectable with either anti-LC #! or antibody pLC2 (lanes 1 in Figures 7B and 7C , respectively). Elevation of the free [Ca# + ] to 1 µM (pCa 6) resulted in contraction and an increase in P " -LC #! ( Figures 7A and 7B , lane 2), but only a small increase in P # -LC #! ( Figure 7C, lane 2) . The stoichiometry of LC #! monophosphorylation in demembranated muscle strips at the plateau of force development in response to pCa 6 (0.19p0.06 mol of P i \mol of LC #! , n l 5) was similar to the basal level of LC #! phosphorylation in intact muscle strips ( Figure 1 ) and markedly less than the levels determined at the peak of contraction in intact strips stimulated with 117 mM KCl (0.61p0.06 mol of P i \mol of LC #! , n l 4), despite reaching similar levels of tension [246p17 mg (n l 5) and 255p26 mg (n l 7), respectively]. At pCa 4.5, there were further increases in LC #! monophosphorylation ( Figure 7B , lane 3) and diphosphorylation ( Figure 7C, lane 3) , but increasing the free [Ca# + ] to pCa 4.5 at the plateau of force development at pCa 6 caused only a slight increase in force (results not shown). Inhibition of PP1 M by microcystin at pCa 9 caused a marked increase in LC #! monophosphorylation ( Figure 7B , lane 4) and diphosphorylation ( Figures 7B and 7C, lanes 4) , while steady-state force was comparable with that evoked at pCa 6 [28] . LC #! mono-and diphosphorylation in response to K + depolarization are shown for comparison in Figures 7(B) and 7(C), lanes 5.
Contraction of demembranated muscle strips and LC #! monophosphorylation at pCa 6 were inhibited significantly by ML-9 and wortmannin, but not by chelerythrine or calphostin C (Figure 8 ), indicating that MLCK and not PKC is responsible for this Ca# + -induced LC #! monophosphorylation. This is consistent with the loss of PKCs α and β following detergent treatment ( Figure 6B ).
Tension-LC 20 phosphorylation relationships
The relationships between tension and LC #! phosphorylation for intact and demembranated rat tail arterial smooth muscle are shown in Figure 9 . In intact muscle strips there is a sigmoidal relationship between LC #! monophosphorylation and tension with increases in force occurring over the range of $ 0.3-0.5 mol of P i \mol of LC #! ( Figure 9A ). In demembranated muscle strips, on the other hand, the tension-LC #! monophosphorylation relationship is hyperbolic with maximal force achieved at 0.2 mol of P i \mol of LC #! ( Figure 9A ). Contractions induced in demembranated muscle strips by the phosphatase inhibitor microcystin in the absence of Ca# + displayed a tension-LC #! monophosphorylation relationship intermediate between intact and demembranated strips treated with cirazoline and Ca# + , respectively ( Figure 9A) . No relationship was observed between LC #! diphosphorylation and tension ( Figure 9B ).
DISCUSSION
It is well accepted that MLCK triggers smooth-muscle contraction via LC #! monophosphorylation at Ser-19. However, questions remain to be answered regarding the involvement of other kinases (PKC, ROK, Ca# + -independent LC #! kinase and others) in the regulation of contraction. We have used two MLCK inhibitors and two PKC inhibitors to investigate the roles of these kinases in LC #! phosphorylation under basal and agonist-stimulated conditions. In intact rat tail arterial smoothmuscle strips, basal LC #! monophosphorylation is due to MLCK. α " -Adrenoceptor stimulation increases LC #! monophosphorylation via MLCK and PKC activation. Inhibition of PKC by chelerythrine or calphostin C had no significant effect on resting [Ca# + ] i or the increase in [Ca# + ] i evoked by α " -adrenoceptor stimulation. It should be emphasized that ROK may also be activated in response to α " -adrenoceptor stimulation and may contribute to LC #! phosphorylation via inhibition of PP1 M [42] . In demembranated rat tail arterial smooth-muscle strips, MLCK mediated the Ca# + -induced contraction and LC #! monophosphorylation. It is of interest that cirazoline-induced contraction of intact rat tail arterial smooth-muscle strips is much more sensitive to ML-9 than is Ca# + -induced contraction of demembranated muscle strips (compare Figures 3A and 8A) . This is probably due to the different tension-LC #! phosphorylation relations in intact and demembranated strips (see below). Very low levels of P # -LC #! were detected in demembranated muscle strips contracted at pCa 6.
During the course of this work, we observed a relationship between LC #! phosphorylation and contractile force similar to those in studies with other smooth-muscle tissues (e.g. [43] [44] [45] [46] [47] ). The results of the present study show that no clear relationship exists between steady-state tension and the very low levels of Smooth-muscle myosin phosphorylation ) is PKCs α and β, which are also recognized by this antibody. Two faint bands of lower molecular mass than PKCζ are also detected by the antibody, but represent non-specific bands since they were also seen in the presence of the competing peptide antigen. Slight proteolysis of MLCK and PP1 c is evident in (E) and (G), respectively. SM22 is a 22 kDa smooth-muscle protein of unknown function [52] .
LC
#! diphosphorylation detected in either intact or demembranated rat tail arterial smooth muscle ( Figure 9B ). We conclude, therefore, that Ser-19 phosphorylation plays a critical role in contraction whereas Thr-18 phosphorylation has no apparent role in the contractile response in normal rat tail arterial smooth muscle in response to membrane depolarization or α " -adrenoceptor stimulation. Diphosphorylation of LC #! may however play a role in other smooth-muscle tissues, in response to other stimuli, or in pathophysiological conditions such as coronary artery spasm [48] [49] [50] .
Another interesting aspect of the present study is the large difference in the relationship between LC #! monophosphorylation and steady-state tension in intact compared with demembranated rat tail arterial smooth-muscle strips. Demembranated muscle strips showed a steep relationship that reached a plateau in tension at $ 20 % phosphorylated LC #! , in good agreement with previous studies of permeabilized smooth muscle (e.g. [44, 46] ) and as predicted by the ' latch bridge ' model of Hai and Murphy [43] . In intact muscle strips, on the other hand, there is a significant basal level of LC #! phosphorylation and a more gradual increase in tension with increases in LC #! phosphorylation. The latch bridge model assumes that slowly cycling, dephosphorylated cross-bridges (latch bridges) arise from the activity of PP1 M on phosphorylated cross-bridges and contribute to steady-state tension. Under conditions of high phosphatase activity, more latch bridges will form, leading to a steeper relationship between tension and LC #! phosphorylation. On the other hand, under conditions of low phosphatase activity, the relationship will be less steep. Based on the latch bridge model, the results of the present study suggest that there is a high level of phosphatase activity in demembranated compared with intact rat tail artery, perhaps due to the loss of the phosphatase inhibitor, CPI-17. A previous study demonstrated preferential extraction of PP1 M over MLCK upon treatment of Triton X-100- demembranated chicken gizzard fibres for 10 h at 37 mC in glycerol-containing relaxing solution [46] . The method of demembranation employed in the present study was relatively mild, involving treatment with 1 % Triton X-100 at 20 mC for only 2 h in the absence of glycerol. In fact, Western blots revealed that MLCK and the catalytic and myosin-binding subunits of PP1 M were retained in demembranated rat tail arterial strips ( Figures  6E-6G ). Thus the possibility that preferential removal of the phosphatase led to an artificially high ratio of kinase\ phosphatase activity in demembranated strips seems unlikely with the protocol used in the present study. Loss of additional proteins such as calponin and SM22 has been suggested to contribute to the steep relationship between LC #! phosphorylation and contraction [46] . However, calponin was also retained in demembranated arterial strips ( Figure 6C ). We did not blot for SM22, but from Coomassie Brilliant Blue-stained gels of intact and demembranated arterial strips, it was also retained ( Figure 6A ). The most likely explanation for the difference in relationship between intact and demembranated rat tail arteries is a large increase in phosphatase activity after demembranation that may be related to the loss of, for example, a PKC isoenzyme and\or CPI-17. In support of this, inhibition of PP1 M with microcystin at pCa 9 ( Figure 9A ) produced a tension-LC #! phosphorylation relationship intermediate between those observed for intact and demembranated rat tail arteries. This observation suggests that differences in phosphatase activity between intact and demembranated arteries is a major contributor to the difference in the tension-LC #! phosphorylation relationship. This is in contrast to results obtained with permeabilized rabbit portal vein [51] or mesenteric artery [47] , in which treatment with a phosphatase inhibitor (okadaic acid or calyculin A, respectively) did not alter the relationship between maximal force output and LC #! phosphorylation, but is similar to the rightward shift in the tension-LC #! phosphorylation relationship observed on treatment of Triton X-100-demembranated chicken gizzard smooth-muscle strips with okadaic acid [46] .
In conclusion, the results of the present study show that : (i) basal LC #! monophosphorylation in intact rat tail arterial smooth muscle is due to MLCK ; (ii) α " -adrenoceptor stimulation increases LC #! monophosphorylation via MLCK and PKC activation ; (iii) in demembranated rat tail arterial smooth-muscle strips, Ca# + -induced LC #! monophosphorylation is effected by MLCK, consistent with the loss of PKCs α and β following detergent treatment ; (iv) very little LC #! diphosphorylation occurs in intact or demembranated muscle strips at rest or in response to contractile stimuli ; (v) the steady-state tension-LC #! monophosphorylation relationship is markedly different between intact and demembranated rat tail arterial smooth muscle. This difference supports the latch-bridge hypothesis and could be explained by a higher phosphatase\kinase activity ratio in demembranated compared with intact arteries. This may be due to disruption of a signalling pathway leading to PP1 M inhibition upon Triton X-100 treatment, e.g. loss of an important PKC isoenzyme and\or CPI-17 that lead to phosphorylation and inhibition of PP1 M .
